MS
TECX

Maven Securities’s Tectonic Therapeutic TECX Stock Holding History

Maven Securities’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,503
Closed -$393K – 1142
2021
Q4 		$393K Buy
+8,503
New +$488K 0.01% 616

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maven Securities's TECX Position: Q1 2022 in Review

Maven Securities sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 8,503 shares — an estimated $393K sold.

Maven Securities first reported a position in TECX in Q4 2021 and held it in 1 quarter. The position peaked at $393K in Q4 2021. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

  • Maven Securities reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
  • Maven Securities sold 8,503 Tectonic Therapeutic shares in Q1 2022, an estimated $393K.
  • Maven Securities first reported a position in Tectonic Therapeutic in Q4 2021 and held it in 1 quarter.
  • Maven Securities's Tectonic Therapeutic position peaked at $393K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on Maven Securities's 13F filing for Q1 2022, filed 16 May 2022.